Censavudine is under clinical development by Transposon Therapeutics and currently in Phase II for Progressive Supranuclear Palsy. According to GlobalData, Phase II drugs for Progressive Supranuclear ...
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share ...
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Progressive Supranuclear Palsy. According to GlobalData, Phase II drugs for Progressive Supranuclear ...
2 School of Philosophy, Psychology and Language Sciences (PPLS) & Centre for Clinical Brain Sciences (CCBS), University of Edinburgh, Edinburgh, UK ...
These features, atypical of progressive supranuclear palsy, suggested the diagnosis of Whipple’s disease, which was subsequently confirmed by polymerase chain reaction analysis of intestinal biopsy ...
The four-repeat (4R) tau pathology was recently identified in the peripheral nervous system of patients with progressive supranuclear palsy. Consequently, a 4R tau seeding assay using skin tissue from ...
Signs of cerebral palsy in infants often show up as developmental delays, involuntary movements, and abnormal muscle tone. Cerebral palsy may be caused by an injury during birth — and parents may be ...
progressive supranuclear palsy) and motor neurone disease. The finding of neurologic signs in addition to cognitive impairments in the mild and moderate stages of dementia suggests a diagnosis ...
Progressive sells several different types of vehicle and property insurance. It’s one of the largest auto insurers in the U.S. and offers competitive rates as well as a wide range of discounts ...